BSR myositis guideline: What does this mean for patients?
Apr 1, 2022 - 15:17
Radio and PodcastLive Radio & PodcastsScience & Medicine
De novo lupus nephritis and belimumab
Dr. Anastasia Madenidou asks Prof. Christopher Sjöwall (Linköping, Sweden) about de novo lupus nephritis (LN) during treatment with belimumab. They discuss the process of collecting these observational data, the approval...
Related Episodes
Continue listening to more episodes from Rheumatology, Oxford Journals.
BSR myositis guideline: What does this mean for patients?
Apr 1, 2022 - 15:17
BSR myositis guideline: Clinical updates
Mar 31, 2022 - 26:57
BSR myositis guideline: Clinical updates
Mar 31, 2022 - 26:57
Improving outcomes for hospitalised gout patients
Mar 16, 2022 - 13:38
Improving outcomes for hospitalised gout patients
Mar 16, 2022 - 13:38
Safety and clinical activity of atacicept in SLE
Mar 10, 2022 - 05:39
Safety and clinical activity of atacicept in SLE
Mar 10, 2022 - 05:39